This bill is related to health care and specifically addresses the issue of drug accessibility in Oregon. The bill has two major components. Firstly, the bill restricts the actions of drug manufacturers by preventing them from making it harder for pharmacies or drug outlets to acquire or deliver specific drugs, known as 340B drugs. These 340B drugs refer to drugs offered at reduced prices under the federal 340B Drug Pricing Program, which requires drug manufacturers to offer drugs at reduced prices to health care organizations that care for underserved populations. Secondly, the bill mandates the Oregon Health Authority (OHA) to study the issues in accessing health care services in the state. OHA must then report its findings to legislative committees related to health.